We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




In Vitro Culture System Yields Clues About Embryonic Blood Cell Development

By LabMedica International staff writers
Posted on 20 Mar 2016
Developmental researchers employed a robust in vitro culture system, which models HSC (hematopoietic stem cell) development in the embryo, to study how these cells give rise to the various types of blood cells found in the adult.

Developing HSCs are embedded in the complex embryonic AGM (aorta–gonad–mesonephros) microenvironment. More...
The AGM region is derived from the mesoderm layer of the embryo. During organogenesis (around the fourth week in human embryos), the visceral region of the mesoderm, the splanchnopleura, transforms into distinct structures consisting of the dorsal aorta, genital ridges, and mesonephros. For a period during embryonic development, the dorsal aorta produces hematopoietic stem cells, which eventually colonize the liver and give rise to all mature blood lineages in the adult. By birth, the dorsal aorta has become the descending aorta, while the genital ridges have formed the gonads. The mesonephros have formed nephrons and other associated structures of the kidneys.

The location for HSC development suggested that this process may require signals derived from different compartments of the AGM region. Investigators at the University of Edinburgh (United Kingdom) sought to test this hypothesis. However, the analysis of HSC development in vivo was significantly hampered by low accessibility of embryos developing in utero, fast maturation of HSCs into mature blood cells, and lack of uniquely specific markers for HSC precursors and their low numbers in the AGM region.

To overcome these difficulties, the investigators developed a cell culture system that modeled HSC development in the embryo, and used it in combination with functional HSC analysis using long-term reconstitution assays in mice.

Results obtained with these tools were published in the March 8, 2016, online edition of the journal Nature Communications. The investigators reported that stage-specific reciprocal dorsoventral inductive interactions and lateral input from the urogenital ridges were required to drive HSC development in the aorta. Furthermore, the results suggested that these inductive interactions in the AGM region were mediated by the interplay between spatially polarized signaling pathways. Specifically, Shh (Sonic hedgehog) produced in the dorsal region of the AGM, stem cell factor in the ventral and lateral regions, and BMP (Bone morphogenetic protein) inhibitory signals in the ventral tissue were integral parts of the regulatory system involved in the development of HSCs.

Senior author Dr. Alexander Medvinsky, professor of hematopoietic stem cell biology at the University of Edinburgh, said, "There is a pressing need to improve treatments for diseases like leukemia and this type of research brings us a step closer to that milestone. The more we understand about how embryos develop these blood stem cells, the closer we come to being able to make them in the lab."

Related Links:

University of Edinburgh



New
Gold Member
Latex Test
SLE-Latex Test
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Clostridium Difficile Toxin A+B Combo Card Test
CerTest Clostridium Difficile Toxin A+B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.